3 Beaten-Up Healthcare Stocks: Are They Bargains?


Beaten-up healthcare stocks can rebound in the blink of an eye, making them a great place to look for unusual growth opportunities. Keeping with this theme, I think Bristol-Myers Squibb Bristol's shares have lost 27% from their highs this year, thanks to Opdivo's flame-out in front-line non-small-cell lung cancer .



from Biotech News